Literature DB >> 8182064

Tumor necrosis factor and lymphotoxin. Qualitative and quantitative differences in the mediation of early and late cellular response.

M M Chaturvedi1, R LaPushin, B B Aggarwal.   

Abstract

Tumor necrosis factor (TNF) is a 17-kDa protein produced by monocytes and a wide variety of other cell types in response to endotoxin and other cytokines. In contrast, lymphotoxin (LT) is a 25-kDa glycoprotein produced only by lymphocytes activated by mitogens. These two cytokines are 28% identical in their amino acid sequences. As they have common cell surface receptors, it is generally assumed that all cellular responses mediated through TNF are also mediated by LT and vice versa. In this report we tested this assumption, comparing the effect of TNF and LT on mediation of early (activation of the transcription factor NF-kappa B) and late (reduction of nitro blue tetrazolium, NBT) cellular responses in the human myelomonoblastic leukemic cell line ML-1a. Both qualitative and quantitative differences were found. LT was found to display 5-10 times more potent antiproliferative effects against murine fibroblasts than TNF. However, in ML-1a cells at concentrations wherein TNF activated NF-kappa B, LT did not. Higher concentrations (1,000-10,000 fold) of LT could activate NF-kappa B, but the activated complex was short lived (less than 1 h versus greater than 6 h when activated by TNF) and required longer treatment (15 min versus less than 5 min). TNF induced NBT-reducing activity in a dose-dependent manner, whereas LT was essentially inactive. Since both TNF and LT have been shown to bind to a common receptor, we tested whether the TNF-induced effects could be blocked by LT. LT inhibited both the early and late TNF-mediated cellular responses. By using receptor-blocking antibodies we found that both p60 and p80 forms of TNF receptors were functional for NBT-reducing activity, but TNF-dependent NF-kappa B activation required only the p60 receptor. Furthermore, we found that both TNF and LT bound with higher affinity to the p80 than to the p60 receptor. Thus, our overall results indicate that there are qualitative and quantitative differences in the action of TNF and LT, and these could be noted quite early in their signaling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182064

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Deficiency of lymphotoxin-α does not exacerbate high-fat diet-induced obesity but does enhance inflammation in mice.

Authors:  Nathalie Pamir; Timothy S McMillen; Kimberly A Edgel; Francis Kim; Renée C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

2.  Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells.

Authors:  Yasunari Takada; Michael Andreeff; Bharat B Aggarwal
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

3.  Linking sister chromatid cohesion and apoptosis: role of Rad21.

Authors:  Debananda Pati; Nenggang Zhang; Sharon E Plon
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

4.  Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake.

Authors:  Vivek R Yadav; Sahdeo Prasad; Ramaswamy Kannappan; Jayaraj Ravindran; Madan M Chaturvedi; Lauri Vaahtera; Jaakko Parkkinen; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

Review 5.  Major apoptotic mechanisms and genes involved in apoptosis.

Authors:  Yağmur Kiraz; Aysun Adan; Melis Kartal Yandim; Yusuf Baran
Journal:  Tumour Biol       Date:  2016-04-09

6.  Crotepoxide chemosensitizes tumor cells through inhibition of expression of proliferation, invasion, and angiogenic proteins linked to proinflammatory pathway.

Authors:  Sahdeo Prasad; Vivek R Yadav; Chitra Sundaram; Simone Reuter; Padmanabhan S Hema; Mangalam S Nair; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2010-06-23       Impact factor: 5.157

7.  Calcium-dependent ADP-ribosylation of high-mobility-group I (HMGI) proteins.

Authors:  V Giancotti; A Bandiera; C Sindici; L Perissin; C Crane-Robinson
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

8.  Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes.

Authors:  Sun Ju Choi; Kyoung-Ho Lee; Hyun Sook Park; Soo-Ki Kim; Choon-Myung Koh; Joo Young Park
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

9.  Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.

Authors:  Sahdeo Prasad; Vivek R Yadav; Bokyung Sung; Simone Reuter; Ramaswamy Kannappan; Amit Deorukhkar; Parmeswaran Diagaradjane; Caimiao Wei; Veerabhadran Baladandayuthapani; Sunil Krishnan; Sushovan Guha; Bharat B Aggarwal
Journal:  Clin Cancer Res       Date:  2012-07-25       Impact factor: 12.531

10.  Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma.

Authors:  Hai-Jun Zhou; Lan V Pham; Archito T Tamayo; Yen-Chiu Lin-Lee; Lingchen Fu; Linda C Yoshimura; Richard J Ford
Journal:  Blood       Date:  2007-06-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.